American Journal of Medical and Biological Research
ISSN (Print): 2328-4080 ISSN (Online): 2328-4099 Website: http://www.sciepub.com/journal/ajmbr Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Medical and Biological Research. 2017, 5(2), 18-22
DOI: 10.12691/ajmbr-5-2-2
Open AccessArticle

Downregulation of MMP-9 Level and GCS Score Improvement in Severe Traumatic Brain Injury Due to the Mild Hypothermia Therapy

Eko Prasetyo1, , Andi Asadul Islam2, Mochammad Hatta3, Djoko Widodo2 and Ilhamjaya Pattelongi4

1Departement of Surgery, Division of Neurosurgery, Faculty of Medicine, University of Sam Ratulangi, Manado, Indonesia

2Departement of Surgery, Division of Neurosurgery, Faculty of Medicine, University of Hasanuddin, Makassar, Indonesia

3Molecular Biology and Immunology Laboratory, Faculty of Medicine, University of Hasanuddin, Makassar, Indonesia

4Departement of Physiology, Faculty of Medicine, University of Hasanuddin, Makassar, Indonesia

Pub. Date: September 09, 2017

Cite this paper:
Eko Prasetyo, Andi Asadul Islam, Mochammad Hatta, Djoko Widodo and Ilhamjaya Pattelongi. Downregulation of MMP-9 Level and GCS Score Improvement in Severe Traumatic Brain Injury Due to the Mild Hypothermia Therapy. American Journal of Medical and Biological Research. 2017; 5(2):18-22. doi: 10.12691/ajmbr-5-2-2

Abstract

We recently investigated the effect of the mild hypothermia therapy towards alteration of matrix metalloproteinase-9 (MMP-9) and outcome of severe traumatic brain injury (TBI). The neurologic outcome was assessed by applying with GCS (Glasgow Coma Scale) score. Twenty patients with severe TBI whose the GCS score ≤ 8 between June 2015 and June 2016 were enrolled in RD Kandou Hospital, Manado, Indonesia. Patients were randomized into two groups, with and without the mild hypothermia therapy (34-36°C) which was investigated within 24 and 72 h. The MMP-9 level was estimated using enzyme-linked immunosorbent assay (ELISA). The assessments of outcomes were determined using the GCS score within 24 and 72 h during the mild hypothermia therapy. Our results showed that the level of serum MMP-9 was decreased significantly within 72 h in the mild hypothermia therapy group. The effects of the mild hypothermia therapy toward to the GCS score alteration were noticeable increased and differences were significant in the two groups within 72 h. We concluded that the mild hypothermia therapy diminished MMP-9 protein level and improvement of the GCS score in severe TBI patients within 72 h.

Keywords:
mild hypothermia MMP-9 GCS TBI

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  C.Werner, and Engelhard, “Pathophysiology of traumatic brain injury,” Brit J Anaesth, vol., 99, no.1, pp.4-9, 2007.
 
[2]  M.C.Falo, H, Fillmore, and T.M.Reeves, “Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury”, J Neurosci Res, vol.84, pp.768-781, 2006.
 
[3]  T.Higashida, C.W.Kreipke, J.A.Rafols JA, et al., “The role of hypoxia – inducible factor-1 alpha, aquaporin-4 and matrix metalloproteinase-9 in blood brain barrier disruption and brain edema after traumatic brain injury”, J Neurosurg, vol.114, pp. 92-101, 2011.
 
[4]  M.Kolar, J.Pachl, and H.Tomasova, “Dynamics of matrix-metalloproteinase 9 after brain trauma-results of a pilot study”, Act Neurochir Suppl, vol.102, pp. 373-376, 2008.
 
[5]  D.J.Roberts, C.N.Jenne, C.Léger C, et al., “Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury,” J Neurotrauma, vol.30, pp.1727-1736, 2013.
 
[6]  T.L.Barr, L.L.Latour, K.Y.Lee KY et al., “Blood-brain barrier disruption in humans is independently associated with increased matrix-metalloproteinase-9”, Stroke, vol.41, pp.123-128, 2010.
 
[7]  C.M.Atkins, A.A. Oliva Jr., O.F.Alonso OF et al., “Hypothermia treatments potentiates ERK1/2 activation after traumatic brain injury”, Eur J Neurosci, vol.26, pp.810-819, 2007.
 
[8]  A.R.Jayakumar, X.Y.Tong, R.Ruiz-Cordero et al., “Activation of NF-κB mediates astrocyte swelling and brain edema in traumatic brain injury,” J Neurotrauma,vol.31, pp.1-9, 2014.
 
[9]  T.Mori, X.Wang, T.Aoki, and E.H.Lo, “Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK Mitogen Activated Protein Kinase in traumatic brain injury”, J Neurotrauma, vol 19, pp.1411-1419, 2002.
 
[10]  K.R.L.Schmitt , A. Diestel, S.Lehnardt S , et al. “Hypothermia suppresses inflammation via ERK signaling pathway in stimulated microglial cells,” J Neuroimmunol, vol.189, pp.7-16, 2007
 
[11]  Westermarck J, Kahari W. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J, 13: 781-792, 1999.
 
[12]  Gal R, Cundrle I, Zimova I, Smrcka M. Mild hypothermia therapy for patients with severe brain injury. Clin Neurol Neurosurg, 104: 318-321, 2002.
 
[13]  Jiang JY. Clinical study of mild hypothermia treatment for severe traumatic brain injury. J Neurotrauma 2009; 26: 399-406.
 
[14]  Jiang JY, Yu MK, Zhu C. Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 cases. J Neurosurg 2000; 93: 546-549.
 
[15]  Lei J, Gao G, Mao Q, Feng J, Wang L. Rationale, methodology, and implementation of a nationwide multicenter randomized controlled trial of long-term mild hypothermia for severe traumatic brain injury (the LTH-1 trial). Contemp Clin Trials 2015; 40: 9-14.
 
[16]  Tang C, Bao Y, Qi M, Zhou L, Liu F, Mao J et al. Mild induced hypothermia for patients with a severe traumatic brain injury after decompressive craniectomy. J Crit Care 2017; 39: 267-270.
 
[17]  Dietrich WD. Therapeutic hypothermia in experimental models of traumatic brain injury. In: N. Hayashi, editor. Brain hypothermia. Tokyo: Springer-Verlag, 2000, 39-46.
 
[18]  Dietrich WD, Bramlett HM. The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics 2010; 7(1): 43-50.
 
[19]  Polderman KH. Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1, indications and evidence. Intensive Care Med 2004; 30: 556-575.
 
[20]  Sahuquillo J, Vilalta A. Cooling the injured brain: how does moderate hypothermia influence the pathophysiology of traumatic brain injury. Curr Pharm Des 2007; 13: 2310-2322.
 
[21]  Jurkovich GJ, Pitt RM, Curreri PW, Granger DN. Hypothermia prevents increased capillary permeability following ischemia-reperfusion injury. J Surg Res 1998; 44: 514-521.
 
[22]  Lotocki G, de Rivero Vaccari JP, Perez ER, Sanchez-Molano J, Furones-Alonso O, Bramlett HM, et al. Alterations in blood-brain barrier permeability to large and small molecule and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma 2009; 26: 1123-1134.
 
[23]  Suehiro E, Fujisawa H, Akimura T. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. J Neurotrauma 2004; 21: 1706-1711.
 
[24]  Truettner JS, Alonso OF, Dalton DW. Influence therapeutic hypothermia on matrix metalloproteinases activity after traumatic brain injury in rats. J Cereb Blood Flow Metab 2005; 25: 1505-1516.
 
[25]  Udekwu P, Schiro SK, Vaslef S, Baker C, Oller D. Glasgow Coma Scale Score, Mortality, and Functional Outcome in Head-Injured Patients. J Trauma 2004; 56: 1084-1089.
 
[26]  Balestreri M, Czosnyka M, Chatfield DA, Steiner LA, Schmidt EA, Smielewski P, et al. Predictive value of Glasgow coma scale after brain trauma: change in trend over the past ten years. J Neurol Neurosurg Psychiatry 2004; 75: 161-162.
 
[27]  Jia F, Pan YH, Mao Q, Liang Y, Jiang J. Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. J Neurotrauma 2010; 27: 1059-1068.
 
[28]  Andresen M, Gazmuri JT, Marín A, Regueira T, Rovegno M. Therapeutic hypothermia for acute brain injuries. Scan J Trauma Res Emerg Med 2015; 23(42): 1-7.
 
[29]  Polderman KH. Mechanism of action, physiological effects, and complication of hypothermia. Crit Care Med 2009; 37: S186-202.
 
[30]  Fox JL, Vu EN, Doyle-Waters M, Brubacher JR, Abu-Laban R, Hu Z. Prophylactic hypothermia for traumatic brain injury: a quantitative systematic review. CJEM 2010; 12: 355-364.
 
[31]  Peterson K, Carson S, Carney N. Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma 2008; 25: 62-71.
 
[32]  Yaglom J, O’Callaghan-Sunol, C Gabai V. Inactivation of dual-specificity phosphatases are involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp 72. Mol Cell Biol 2003; 23: 3813-3824.
 
[33]  Han HS, Karabiyikoglu M, Kelly S, Sobel RA, Yenari MA. Mild hypothermia inhibits nuclear factor-kB translocation in experimental stroke. J Cereb Blood Flow Metab 2003; 23: 589-598.
 
[34]  Han HS, Park J, Kim J, Suk K, Molecular and cellular pathways as a target of therapeutic hypothermia: pharmacological aspect. Curr Neuropharmacol 2012; 10: 80-87.
 
[35]  Fini ME, Cook JR, Mohan R, Brinkerhoff CE. Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP, editors. Matrix Metalloproteinases. New York, NY: Academic Press, 1998, 299-356.
 
[36]  Vu TH, Werb Z. Gelatinase B, structure, regulation and function. In: Parks WC, Mecham RP, editors. Matrix Metalloproteinases. New York, NY: Academic Press, 1998, 115-117.
 
[37]  Lee JE, Yoon YJ, Moseley ME, Yenari MA. Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. J Neurosurg 2005; 103: 289-297.